Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function

Cerebellum

Volumn 4, Issue 3, 2005, Pages 162-170

  Sanchez Perez, Ana ^a   Llansola, Marta ^a   Cauli, Omar ^a   Felipo, Vicente ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

cAMP; Motor coordination; Motor learning; Neurotrophic factors; NMDA receptors; Pharmacology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; DEXTRO SERINE; FIBROBLAST GROWTH FACTOR; GLYCINE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; NEUROTRANSMITTER RECEPTOR; NEUROTROPHIC FACTOR; POLYAMINE;

ARTICLE; BINDING SITE; BRAIN FUNCTION; BRAIN MAPPING; CEREBELLUM; HUMAN; LEARNING; MOTOR COORDINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN QUATERNARY STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBELLUM; CYCLIC AMP; POLYAMINES; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 25144473954     PISSN: 14734222     EISSN: None     Source Type: Journal    
DOI: 10.1080/14734220510008003     Document Type: Article

References (94)

1. Yaka R, He DY, Phamluong K, Ron D. Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J Biol Chem. 2003;278:9630-8.
2. Huang CC, Gean PW. Cyclic adenosine-3′,5′-monophosphate potentiates the synaptic potential mediated by NMDA receptors in the amygdala. J Neurosci Res. 1995;40:747-54.
3. Han Y, Wu SM. NMDA-evoked [Ca2+]i increase in salamander retinal ganglion cells: Modulation by PKA and adrenergic receptors. Vis Neurosci. 2002;19(3):249-56.
4. Westphal RS, Tavalin SJ, Lin JW, Alto NM, Fraser ID, Langeberg LK, Sheng M, Scott JD. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 1999;285:93-6.
5. Toms NJ, Roberts PJ. NMDA receptor-mediated stimulation of rat cerebellar nitric oxide formation is modulated by cyclic AMP. Eur J Pharmacol. 1994;266:63-6.
6. Llansola M, Sanchez-Perez AM, Montoliu C, Felipo V. Modulation of NMDA receptor function by cyclic AMP in cerebellar neurones in culture. J Neurochem. 2004;91:591-9.
7. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem. 1997;272:5157-66.
8. Cerne R, Rusin KI, Randic M. Enhancement of the N-methyl-D-aspartate response in spinal dorsal horn neurons by cAMP-dependent protein kinase. Neurosci Lett. 1993;161:124-8.
9. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun. 2000;267(1):129-33.
10. Lindholm D, Dechant G, Heisenberg CP, Thoenen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J Neurosci. 1993;5:1455-64.
11. Marini AM, Rabin SJ, Lipsky RH, Mocchetti I. Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J Biol Chem. 1998;273:29394-9.
12. Favaron M, Manev RM, Rimland JM, Candeo P, Beccaro M, Manev H. NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones. Neuroreport. 1993;4:1171-4.
13. Bhave SV, Ghoda L, Hoffman PL. Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: Signal transduction cascades and site of ethanol action. J Neurosci. 1999;19:3277-86.
14. Levine ES, Crozier RA, Black IB, Plummer MR. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proc Natl Acad Sci USA. 1998;95:10235-9.
15. Matsumoto T, Numakawa T, Adachi N, Yokomaku D, Yamagishi S, Takei N, Hatanaka H. Brain-derived neurotrophic factor enhances depolarization-evoked glutamate release in cultured cortical neurons. J Neurochem. 2001;79:522-30.
16. Lin SY, Wu K, Levine ES, Mount HT, Suen PC, Black IB. BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res Mol Brain Res. 1998;55:20-7.
17. Slack SE, Pezet S, McMahon SB, Thompson SW, Malcangio M. Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord. Eur J Neurosci. 2004;20(7): 1769-78.
18. Fernandez-Sanchez MT, Novelli A. Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity. FEBS Lett. 1993;335:124-31.
19. Brandoli C, Sanna A, De Bernardi MA, Follesa P, Brooker G, Mocchetti I. Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. J Neurosci. 1998;18:7953-61.
20. Lemke G. Neuregulins in development. Mol Cell Neurosci. 1996;7:247-62.
21. Ozaki M, Sasner M, Yano R, Lu HS, Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature. 1997;390:691-4.
22. Williams K. Interactions of polyamines with ion channels. Biochem J. 1997;325(Pt 2):289-97.
23. Williams K, Zappia AM, Pritchett DB, Shen YM, Molinoff PB. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol. 1994;45:803-9.
24. Lerma J. Spermine regulates N-methyl-D-aspartate receptor desensitization. Neuron. 1992;8:343-52.
25. Rock DM, MacDonald RL. Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance. Mol Pharmacol. 1992;42:157-64.
26. Carter CJ, Lloyd KG, Zivkovic B, Scatton B. Ifenprodil and SL 82.0715 as cerebral antischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther. 1990;253:475-82.
27. Williams K. Ifenprodil, a novel NMDA receptor antagonist: Site and mechanism of action. Curr Drug Targets. 2001;2(3): 285-98.
28. Cebere A, Gebers G, Wagner A, Liljequist S. Spermidine attenuates the inhibitory effect of ethanol on NMDA-induced neurotoxicity. Naunyn Schmiedebergs Arch Pharmacol. 2002;366(2):117-22.
29. Sparapani M, Dall'Olio R, Gandolfi O, Ciani E, Contestabile A. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Exp Neurol. 1997;148:157-66.
30. Danysz W, Wroblewski JT, Brooker G, Costa E. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Brain Res. 1989;479:270-6.
31. Rao TS, Cler JA, Emmett MR, Mick SJ, Iyengar S, Wood PL. Glycine, glycinamide and D-serine act as positive modulators of signal transduction at the N-methyl-D-aspartate (NMDA) receptor in vivo: Differential effects on mouse cerebellar cyclic guanosine monophosphate levels. Neuropharmacology. 1990;29:1075-80.
32. Wood PL, Emmett MR, Rao TS, Mick S, Cler J, Iyengar S. In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: Potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. J Neurochem. 1989;53:979-81.
33. Hashimoto A, Oka T, Nishikawa T. Anatomical distribution and postnatal changes in endogenous free D-aspartate and D-serine in rat brain and periphery. Eur J Neurosci. 1995;7:1657-63.
34. Schell MJ, Brady RO, Jr., Molliver ME, Snyder SH. D-serine as a neuromodulator: Regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci. 1997;17:1604-15.
35. Fedele E, Bisaglia M, Raiteri M. D-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:43-7.
36. Miller RF. D-Serine as a glial modulator of nerve cells. Glia. 2004;47(3):275-83.
37. Mothet JP, Parent AT, Wolosker H, Brady RO, Jr., Linden DJ, Ferris CD, Rogawski MA, Snyder SH. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA. 2000;97(9): 4926-31.
38. Hashimoto A, Oka T, Nishikawa T. Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience. 1995;66:635-43.
39. Kumashiro S, Hashimoto A, Nishikawa T. Free D-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatrie diseases. Brain Res. 1995;681:117-25.
40. Rossi P, D'Angelo E, Taglietti V. Differential long-lasting potentiation of the NMDA and non-NMDA synaptic currents induced by metabotropic and NMDA receptor coactivation in cerebellar granule cells. Eur J Neurosci. 1996;8:1182-9.
41. Kinney GA, Slater NT. Potentiation of NMDA receptor-mediated transmission in turtle cerebellar granule cells by activation of metabotropic glutamate receptors. J Neurophysiol. 1993;69:585-94.
42. Courtney MJ, Nicholls DG. Interactions between phospholipase C-coupled and N-methyl-D-aspartate receptors in cultured cerebellar granule cells: Protein kinase C mediated inhibition of N-methyl-D-aspartate responses. J Neurochem. 1992;59:983-92.
43. Minana MD, Hermenegildo C, Llansola M, Montoliu C, Grisolia S, Felipo V. Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons. J Pharmacol Exp Ther. 1996;279:194-9.
44. Montoliu C, Llansola M, Cucarella C, Grisolia S, Felipo V. Activation of the metabotropic glutamate receptor mGluR5 prevents glutamate toxicity in primary cultures of cerebellar neurons. J Pharmacol Exp Ther. 1997;281:643-7.
45. Pizzi M, Boroni F, Bianchetti KM, Memo M, Spano P. Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression. Eur J Neurosci. 1999;11:2489-96.
46. Siliprandi R, Lipartiti M, Fadda E, Sautter J, Manev H. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity. Eur J Pharmacol. 1992;219:173-4.
47. Koh JY, Palmer E, Cotman CW. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in conical cultures. Proc Nad Acad Sci USA. 1991;88:9431-5.
48. Yu SP, Sensi SL, Canzoniero LM, Buisson A, Choi DW. Membrane-delimited modulation of NMDA currents by metabotropic glutamate receptor subtypes 1/5 in cultured mouse cortical neurons. J Physiol. 1997;499(Pt 3):721-32.
49. Tyszkiewicz JP, Gu Z, Wang X, Cai X, Yan Z. Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex. J Physiol. 2004;554(Pt 3):765-77.
50. Harvey J, Collingridge GL. Signal transduction pathways involved in the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices. Br J Pharmacol. 1993;109:1085-90.
51. Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 2001;106(3):579-87.
52. Nicoletti F, Bruno V, Catania MV, Battaglia G, Copani A, Barbagallo G, Cena V, Sanchez-Prieto J, Spano PF, Pizzi M. Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology. 1999;38:1477-84.
53. Bruno V, Battaglia G, Copani A, Cespedes VM, Galindo MF, Cena V, Sanchez-Prieto J, Gasparini F, Kuhn R, Flor PJ, Nicoletti F. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur J Neurosci. 2001;13(8):1469-78.
54. Orlando LR, Alsdorf SA, Penney JB, Jr, Young AB. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp Neurol. 2001;167(1):196-204.
55. Colwell CS, Altemus KL, Cepeda C, Levine MS. Regulation of N-methyl-D-aspartate-induced toxicity in the neostriatum: A role for metabotropic glutamate receptors? Proc Natl Acad Sci USA. 1996;93:1200-4.
56. Dunah AW, Standaert DG. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci. 2001;21(15):5546-58.
57. Didier M, Berman SA, Lindstrom J, Bursztajn S. Characterization of nicotinic acetylcholine receptors expressed in primary cultures of cerebellar granule cells. Brain Res Mol Brain Res. 1995;30:17-28.
58. Vallano ML, Lambolez B, Audinat E, Rossier J. Neuronal activity differentially regulates NMDA receptor subunit expression in cerebellar granule cells. J Neurosci. 1996;16: 631-9.
59. Mogensen HS, Hack N, Balazs R, Jorgensen OS. The survival of cultured mouse cerebellar granule cells is not dependent on elevated potassium-ion concentration. Int J Dev Neurosci. 1994;12:451-60.
60. Resink A, Boer GJ, Balazs R. Treatment with excitatory amino acids or high K+ and NMDA receptors in cerebellar granule cells. Neuroreport. 1992;3:757-60.
61. Oster Y, Schramm M. Down-regulation of NMDA receptor activity by NMDA. Neurosci Lett. 1993;163:85-8.
62. Resink A, Villa M, Boer GJ, Mohler H, Balazs R. Agonist-induced down-regulation of NMDA receptors in cerebellar granule cells in culture. Eur J Neurosci. 1995;7:1700-6.
63. Resink A, Villa M, Benke D, Hidaka H, Mohler H, Balazs R. Characterization of agonist-induced down-regulation of NMDA receptors in cerebellar granule cell cultures. J Neurochem. 1996;66:369-77.
64. Gebers G, Cebere A, Wagner A, Liljequist S. Prolonged inhibition of glutamate reuptake down-regulates NMDA receptor functions in cultured cerebellar granule cells. J Neurochem. 1999;72:2181-90.
65. Oh S, Kim YH, Hann HJ, Lee HL, Choi HS, Kim HS, Ho IK. Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801. Neurochem Res. 2001;26(5):559-65.
66. Skeen GA, Twyman RE, White HS. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol Pharmacol. 1993;44:443-50.
67. Takatsuki K, Kawahara S, Takehara K, Kishimoto Y, Kirino Y. Effects of the noncompetitive NMDA receptor antagonist MK-801 on classical eyeblink conditioning in mice. Neuropharmacology. 2001;41(5):618-28.
68. Thompson LT, Disterhoft JF. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments. J Pharmacol Exp Ther. 1997;281:928-40.
69. Chen G, Steinmetz JE. Intra-cerebellar infusion of NMDA receptor antagonist AP5 disrupts classical eyeblink conditioning in rabbits. Brain Res. 2000;887(1):144-56.
70. Thompson LT, Disterhoft JF. Age- and dose-dependent facilitation of associative eyeblink conditioning by D-cycloserine in rabbits. Behav Neurosci. 1997;111:1303-12.
71. Kishimoto Y, Kawahara S, Kirino Y, Kadotani H, Nakamura Y, Ikeda M, Yoshioka T. Conditioned eyeblink response is impaired in mutant mice lacking NMDA receptor subunit NR2A. Neuroreport. 1997;8:3717-21.
72. Schlett K, Pieri I, Metzger F, Marchetti L, Steigerwald F, Dere E, Kirilly D, Tarnok K, Barabas B, Varga AK, Gerspach J, Huston J, Pfizenmaier K, Kohr G, Eisel UL. Long-term NR2B expression in the cerebellum alters granule cell development and leads to NR2A down-regulation and motor deficits. Mol Cell Neurosci. 2004;27(3):215-26.
73. Kadotani H, Hirano T, Masugi M, Nakamura K, Nakao K, Katsuki M, Nakanishi S. Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J Neurosci. 1996;16:7859-67.
74. Umemori H, Ogura H, Tozawa N, Mikoshiba K, Nishizumi H, Yamamoto T. Impairment of N-methyl-D-aspartate receptor-controlled motor activity in LYN-deficient mice. Neuroscience. 2003;118(3):709-13.
75. Carter AJ. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J Pharmacol Exp Ther. 1994;269:573-80.
76. Contreras PC. D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology. 1990;29:291-3.
77. Danysz W, Essmann U, Bresink I, Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav. 1994;48:111-8.
78. Geter-Douglass B, Witkin JM. Behavioral effects and anti-convulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Psychopharmacology (Berl). 1999; 146:280-9.
79. Haggerty GC, Brown G. Neurobehavioral profile of subcutaneously administered MK-801 in the rat. Neurotoxicology. 1996,17:913-21.
80. Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE. Modulation of MK-801 -induced behaviour by noradrenergic agents in mice. Psychopharmacology (Berl). 2001;154(2): 177-88.
81. Hesselink MB, Smolders H, De Boer AG, Breimer DD, Danysz W, Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration. Behav Pharmacol. 1999;10:85-98.
82. Jerram AH, Smith PF, Darlington CL. A dose-response analysis of the behavioral effects of (+)MK-801 in guinea pig: comparison with CPP. Pharmacol Biochem Behav. 1996;53:799-807.
83. Liljequist S, Ossowska K, Grabowska-Anden M, Anden NE. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol. 1991;195:55-61.
84. Loscher W, Honack D. The behavioural effects of MK-801 in rats: Involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol. 1992;215:199-208.
85. Modes E, Infante C, Gonzalez M. Behavioural motor effects of MK-801 and DNQX parenteral administration in adult cats: Dose-response analysis. Modulatory role of dopaminergic D1 and D2 antagonists on MK-801 induced motor behaviours. Arch Ital Biol. 2000;138(2):167-74.
86. Nakki R, Sharp FR, Sagar SM. FOS expression in the brainstem and cerebellum following phencyclidine and MK801. J Neurosci Res. 1996;43:203-12.
87. Rukoyatkina NI, Gorbunova LV, Gmiro VE, Lukomskaya NY. The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals. Neurosci Behav Physiol. 2003;33(3):273-8.
88. Rupniak NM, Boyce S, Tye S, Cook G, Iversen SD. Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates. Pharmacol Biochem Behav. 1993;44:153-6.
89. Geter-Douglass B, Witkin JM. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Psychopharmacology (Berl). 1999;146: 280-9.
90. Kinoshita K, Watanabe Y, Yamamura M, Matsuoka Y. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats. Eur J Pharmacol. 1998;343:129-33.
91. Saigoh K, Matsui K, Takahashi K, Nishikawa T, Wada K. The stereo-specific effect of D-serine ethylester and the D-cycloserine in ataxic mutant mice. Brain Res. 1998;808:42-7.
92. Contreras PC: D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology. 1990;29:291-3.
93. Tanii Y, Nishikawa T, Hashimoto A, Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharmacol Exp Ther. 1994;269:1040-8.
94. Rogawski MA, Porter RJ. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev. 1990;42:223-86.